![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: IGSF3 |
Gene summary for IGSF3 |
![]() |
Gene information | Species | Human | Gene symbol | IGSF3 | Gene ID | 3321 |
Gene name | immunoglobulin superfamily member 3 | |
Gene Alias | EWI-3 | |
Cytomap | 1p13.1 | |
Gene Type | protein-coding | GO ID | GO:0007275 | UniProtAcc | O75054 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
3321 | IGSF3 | LZE4T | Human | Esophagus | ESCC | 9.76e-24 | 6.48e-01 | 0.0811 |
3321 | IGSF3 | LZE7T | Human | Esophagus | ESCC | 7.65e-07 | 4.74e-01 | 0.0667 |
3321 | IGSF3 | LZE20T | Human | Esophagus | ESCC | 2.94e-02 | 5.26e-02 | 0.0662 |
3321 | IGSF3 | P1T-E | Human | Esophagus | ESCC | 7.48e-03 | 1.52e-01 | 0.0875 |
3321 | IGSF3 | P2T-E | Human | Esophagus | ESCC | 5.65e-22 | 3.51e-01 | 0.1177 |
3321 | IGSF3 | P4T-E | Human | Esophagus | ESCC | 4.62e-14 | 4.18e-01 | 0.1323 |
3321 | IGSF3 | P5T-E | Human | Esophagus | ESCC | 4.66e-20 | 3.64e-01 | 0.1327 |
3321 | IGSF3 | P8T-E | Human | Esophagus | ESCC | 7.26e-07 | 1.15e-01 | 0.0889 |
3321 | IGSF3 | P9T-E | Human | Esophagus | ESCC | 3.72e-12 | 3.01e-01 | 0.1131 |
3321 | IGSF3 | P10T-E | Human | Esophagus | ESCC | 1.85e-40 | 7.38e-01 | 0.116 |
3321 | IGSF3 | P11T-E | Human | Esophagus | ESCC | 1.79e-12 | 8.13e-01 | 0.1426 |
3321 | IGSF3 | P12T-E | Human | Esophagus | ESCC | 1.15e-20 | 5.25e-01 | 0.1122 |
3321 | IGSF3 | P15T-E | Human | Esophagus | ESCC | 7.30e-12 | 2.36e-01 | 0.1149 |
3321 | IGSF3 | P16T-E | Human | Esophagus | ESCC | 3.30e-11 | 3.62e-02 | 0.1153 |
3321 | IGSF3 | P17T-E | Human | Esophagus | ESCC | 8.29e-05 | 2.40e-01 | 0.1278 |
3321 | IGSF3 | P20T-E | Human | Esophagus | ESCC | 1.11e-05 | 1.72e-01 | 0.1124 |
3321 | IGSF3 | P21T-E | Human | Esophagus | ESCC | 5.26e-32 | 7.06e-01 | 0.1617 |
3321 | IGSF3 | P22T-E | Human | Esophagus | ESCC | 4.38e-32 | 4.97e-01 | 0.1236 |
3321 | IGSF3 | P23T-E | Human | Esophagus | ESCC | 5.47e-18 | 4.59e-01 | 0.108 |
3321 | IGSF3 | P24T-E | Human | Esophagus | ESCC | 2.24e-07 | 8.29e-02 | 0.1287 |
Page: 1 2 3 4 5 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0048732111 | Esophagus | ESCC | gland development | 269/8552 | 436/18723 | 7.81e-12 | 2.95e-10 | 269 |
GO:004873222 | Liver | HCC | gland development | 242/7958 | 436/18723 | 2.26e-08 | 5.28e-07 | 242 |
GO:004873220 | Oral cavity | OSCC | gland development | 226/7305 | 436/18723 | 2.78e-08 | 5.39e-07 | 226 |
GO:0048732110 | Oral cavity | LP | gland development | 149/4623 | 436/18723 | 4.51e-06 | 9.17e-05 | 149 |
GO:004873227 | Skin | cSCC | gland development | 167/4864 | 436/18723 | 7.64e-09 | 2.44e-07 | 167 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
IGSF3 | SNV | Missense_Mutation | c.1907N>A | p.Arg636Gln | p.R636Q | O75054 | protein_coding | deleterious(0.01) | probably_damaging(0.99) | TCGA-AP-A0LM-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | SD | |
IGSF3 | SNV | Missense_Mutation | novel | c.206N>C | p.Val69Ala | p.V69A | O75054 | protein_coding | deleterious(0) | benign(0.174) | TCGA-AP-A1DK-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
IGSF3 | SNV | Missense_Mutation | rs374679252 | c.1430N>A | p.Arg477His | p.R477H | O75054 | protein_coding | deleterious(0.04) | probably_damaging(0.943) | TCGA-AX-A0IZ-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
IGSF3 | SNV | Missense_Mutation | rs752933561 | c.1346G>A | p.Arg449His | p.R449H | O75054 | protein_coding | tolerated(0.49) | benign(0) | TCGA-AX-A2HC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | paclitaxel | PD |
IGSF3 | SNV | Missense_Mutation | novel | c.1202N>A | p.Pro401His | p.P401H | O75054 | protein_coding | tolerated(0.08) | probably_damaging(0.964) | TCGA-AX-A2IN-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | PD |
IGSF3 | SNV | Missense_Mutation | novel | c.800N>T | p.Ser267Phe | p.S267F | O75054 | protein_coding | deleterious(0) | probably_damaging(0.979) | TCGA-AX-A2IN-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | PD |
IGSF3 | SNV | Missense_Mutation | rs146751671 | c.791G>A | p.Arg264Gln | p.R264Q | O75054 | protein_coding | tolerated(0.09) | benign(0.007) | TCGA-B5-A11E-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
IGSF3 | SNV | Missense_Mutation | novel | c.1153G>A | p.Val385Met | p.V385M | O75054 | protein_coding | tolerated(0.08) | benign(0.392) | TCGA-B5-A11H-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Hormone Therapy | megace | SD |
IGSF3 | SNV | Missense_Mutation | rs553592752 | c.3221G>A | p.Arg1074His | p.R1074H | O75054 | protein_coding | deleterious(0.01) | possibly_damaging(0.621) | TCGA-B5-A3FC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
IGSF3 | SNV | Missense_Mutation | rs774101250 | c.2860C>T | p.Arg954Trp | p.R954W | O75054 | protein_coding | tolerated(0.21) | possibly_damaging(0.614) | TCGA-B5-A3FC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |